The 'mRNA-1273' vaccine to combat the COVID-19 Corona Virus is ready to be tested on humans.
Image Souece Pixabay By Pete Linforth
Trials for a CoronaVirus vaccine can begin in late April, antihydrogen offers clues about the antimatter mystery of great material and a powerful tool for synthetic biologists.
The vaccine has been sent to the National Institute of Allergy and Infectious Diseases (NIAID) in Bethesda, Maryland.
I think this is the first trial of a CoronaVirus vaccine in humans, the first results are expected as desired.
"This is a new record, entering the first phase of the trial in just three months. Nothing has ever run that fast,"
The impact of the vaccine trial caused Moderna's stock price to rise 19% on February 25, 2020, to around USD22 per share. Is the news really like that?
I think this will attract the attention of other drug makers too, competing to develop vaccines against the CoronaVirus, including Sanofi, Inovio Pharmaceuticals, Novavax and Johnson & Johnson.
Indeed, as we know, the CoronaVirus is too dangerous to be officially known as COVID-19, which has infected more than 80,000 people and killed nearly 3,000 people.
My environment
"Before this case occurred around me shouting (Fight Drugs) but why now the people around me replace the words (Fight Drugs) with the word (CoronaVirus)"